Danielle Murphy

Company: Pfizer

Job title: Director, Translational Oncology

Seminars:

Unveiling the Impact of Liquid Biopsy Combination Therapies on Resistance to Cancer Treatments to Aid the Selection of Combination Regimens with Best-In-Class Therapies 11:30 am

 Characterization of resistance alterations obtained from targeted therapy Using liquid biopsies to study clonal and sub-clonal evolution Identify biomarkers that predict synergy (one therapy affecting the other), to aid the selection of optimal combination regimensRead more

day: Day One Track B AM